Studies have indicated that, at ecologically significant levels, it can mitigate the adverse consequences of several chemotherapy drugs (like doxorubicin, cisplatin, and vinblastine) in ER-alpha-positive and -negative breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.